Literature DB >> 21183949

Direct gene transfer of adenoviral-mediated interferon α into human bladder cancer cells but not the bystander factors produced induces endoplasmic reticulum stress-related cytotoxicity.

X-Q Zhang1, Z Yang, W F Benedict.   

Abstract

We have previously shown that adenoviral-mediated interferon α (Ad-IFNα) is cytotoxic both to cells that are sensitive to recombinant interferon α (IFNα) and to cells which are resistant to IFNα. The cancer cell-specific cytotoxic effects of Ad-IFNα involve three different mechanisms: 1. The direct effect of IFNα production causing cancer cell death in IFNα sensitive cells (1); 2. The direct effect of Ad-IFNα infection and high levels of IFNα expression in IFNα resistant cancer cells (2); and 3. The indirect effect of the Ad-IFNα bystander factors produced (2-4). After Ad-IFNα infection, the cells produce a large amount of perinuclear localized IFN protein. This protein over-load could be a major factor in the direct cancer cell death of those cells infected with Ad-IFNα compared with the indirect cytotoxic effects of the bystander factors produced. Here, we investigated whether a component of Ad-IFN-induced cell death involves protein overload-induced endoplasmic reticulum (ER) stress, using an IFNα-resistant human bladder cancer cell line (KU7), and the normal human urothelial cell line, TERT-NHUC, as preclinical models. We found that the two ER stress response pathways examined were activated in KU7 cells. In contrast, following treatment of the normal TERT-NHUC cells with Ad-IFNα, no ER stress signals were observed. In addition, no ER stress related changes were seen, when KU7 cells were exposed to conditioned medium from Ad-IFNα-treated KU7 cells, indicating that bystander produced cytotoxicity did not involve ER stress. After 24 h of Ad-IFNα infection, the KU7 cancer cells produced spliced X-box binding protein 1 and activating transcription factor 6 protein (ATF6), evoking an ER stress response that could contribute to Ad-IFNα induced apoptosis in these cancer cells. In addition, GADD153/CHOP, GADD34 and BAX were also subsequently modified following activation of the ER stress pathways, thereby signaling downstream effectors in a pro-apoptotic manner.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21183949      PMCID: PMC3970572          DOI: 10.1038/cgt.2010.76

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  8 in total

1.  Structure of Bax: coregulation of dimer formation and intracellular localization.

Authors:  M Suzuki; R J Youle; N Tjandra
Journal:  Cell       Date:  2000-11-10       Impact factor: 41.582

2.  Role of tumor necrosis factor-related apoptosis-inducing ligand in interferon-induced apoptosis in human bladder cancer cells.

Authors:  Angela Papageorgiou; Laura Lashinger; Randall Millikan; H Barton Grossman; William Benedict; Colin P N Dinney; David J McConkey
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

3.  Adenoviral-mediated interferon alpha overcomes resistance to the interferon protein in various cancer types and has marked bystander effects.

Authors:  X Zhang; Z Yang; L Dong; A Papageorgiou; D J McConkey; W F Benedict
Journal:  Cancer Gene Ther       Date:  2006-11-10       Impact factor: 5.987

4.  Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein.

Authors:  William F Benedict; Ziming Tao; Chang-Soo Kim; Xinqiao Zhang; Jain-Hua Zhou; Liana Adam; David J McConkey; Angela Papageorgiou; Mark Munsell; Jennifer Philopena; Heidrun Engler; William Demers; Daniel C Maneval; Colin P N Dinney; Robert J Connor
Journal:  Mol Ther       Date:  2004-09       Impact factor: 11.454

5.  Autophagy is induced by adenoviral-mediated interferon alpha treatment in interferon resistant bladder cancer and normal urothelial cells as a cell death protective mechanism but not by the bystander factors produced.

Authors:  X-Q Zhang; K Dunner; W F Benedict
Journal:  Cancer Gene Ther       Date:  2010-05-21       Impact factor: 5.987

6.  Conditioned medium from Ad-IFN-alpha-infected bladder cancer and normal urothelial cells is cytotoxic to cancer cells but not normal cells: further evidence for a strong bystander effect.

Authors:  X Zhang; L Dong; E Chapman; W F Benedict
Journal:  Cancer Gene Ther       Date:  2008-07-11       Impact factor: 5.987

7.  Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis.

Authors:  A Gross; J Jockel; M C Wei; S J Korsmeyer
Journal:  EMBO J       Date:  1998-07-15       Impact factor: 11.598

8.  Measuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon alpha: possible use as a surrogate marker.

Authors:  M B Fisher; X-Q Zhang; D J McConkey; W F Benedict
Journal:  Cancer Gene Ther       Date:  2009-02-06       Impact factor: 5.987

  8 in total
  3 in total

1.  Direct cytotoxicity produced by adenoviral-mediated interferon α gene transfer in interferon-resistant cancer cells involves ER stress and caspase 4 activation.

Authors:  Z Yang; X-Q Zhang; C N P Dinney; W F Benedict
Journal:  Cancer Gene Ther       Date:  2011-06-17       Impact factor: 5.987

2.  Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer.

Authors:  Colin P N Dinney; Mark B Fisher; Neema Navai; Michael A O'Donnell; David Cutler; Alice Abraham; Sophia Young; Beth Hutchins; Maria Caceres; Narendra Kishnani; George Sode; Constance Cullen; Guangcheng Zhang; H Barton Grossman; Ashish M Kamat; Marshall Gonzales; Michael Kincaid; Nancy Ainslie; Daniel C Maneval; Matthew F Wszolek; William F Benedict
Journal:  J Urol       Date:  2013-03-15       Impact factor: 7.450

3.  Use of monitoring levels of soluble forms of cytokeratin 18 in the urine of patients with superficial bladder cancer following intravesical Ad-IFNα/Syn3 treatment in a phase l study.

Authors:  W F Benedict; M Fisher; X-Q Zhang; Z Yang; M F Munsell; C N P Dinney
Journal:  Cancer Gene Ther       Date:  2014-02-07       Impact factor: 5.987

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.